View Author
patient disease pompe disease pompe muscle study children therapy function enzyme replacement therapy group enzyme adult treatment erasmus mc university value van der ploeg muscle strength storage chemotherapy glycogen center erasmu netherland memory b cells enzyme therapy strength score table hearing weakness memory month control range lysosomal lymphocytes van der beek rotterdam ficiency university percentage signi muscle weakness b cells department result position disorder van doorn pa infantile-onset pompe disease supine position speech replacement blood motor acid maltase van capelle reuser motor function test reference values pompe patients number reference z-score supine reuser aj erasmus mc disease duration compartment level ventilation ploeg lymphoblastic leukemia diagnosis fi rst symptoms signi ficantly gingival overgrowth leukemia bone mineral density
10 Most Recent Publications
|
Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy
(Article)
Gelder, C.M. van Capelle, C.I. van Ploeg, A.T. van der Ebbink, B.J. Moor-van Nugteren, I. Hout, J.M.P. van den Hakkesteegt, M.M. Doorn, P.A. van Coo, I.F.M. de Reuser, A.J.J. Gier, H.H.W. de |
2011-10-18
|
|
The quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients
(Article)
Capelle, C.I. van Beek, N.A.M.E. van der Vries, J.M. de Doorn, P.A. van Duivenvoorden, H.J. Leshner, R.T. Hagemans, M.L.C. Ploeg, A.T. van der |
2011-09-13
|
|
Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease
(Article)
Beek, N.A.M.E. van der Capelle, C.I. van Velden-van Etten, K.I. van der Hop, W.C.J. Berg, B. van den Reuser, A.J.J. Doorn, P.A. van Ploeg, A.T. van der Stam, H. |
2011-09-01
|
|
Gingival overgrowth in pompe disease: A case report
(Article)
Gijt, J.P. de Capelle, C.I. van Oosterhuis, J.W. Ploeg, A.T. van der Wal, K.G.H. van der |
2011-08-01
|
|
Effect of enzyme therapy in juvenile patients with Pompe disease: A three-year open-label study
(Article)
Capelle, C.I. van Beek, N.A.M.E. van der Puga, A.C. Reuser, A.J.J. Ploeg, A.T. van der Hagemans, M.L.C. Arts, W.F.M. Hop, W.C.J. Lee, P. Jaeken, J. Frohn-Mulder, I.M.E. Merkus, P.J.F.M. Corzo, D. |
2010-12-01
|
|
Hearing loss in Pompe disease revisited: results from a study of 24 children
(Article)
Capelle, C.I. van Goedegebure, A. Homans, N.C. Hoeve, L.J. Reuser, A.J.J. Ploeg, A.T. van der |
2010-10-01
|
|
Low bone mass in Pompe disease. Muscular strength as a predictor of bone mineral density
(Article)
Berg, L.E.M. van den Zandbergen, A.A.M. Capelle, C.I. van Vries, J.M. de Hop, W.C.J. Hout, J.M.P. van den Reuser, A.J.J. Zillikens, M.C. Ploeg, A.T. van der |
2010-09-01
|
|
PAS-positive lymphocyte vacuoles can be used as diagnostic screening test for Pompe disease
(Article)
Hagemans, M.L.C. Stigter, R.L. Capelle, C.I. van Beek, N.A.M.E. van der Winkel, L.P.F. Vliet, L. van Hop, W.C.J. Reuser, A.J.J. Beishuizen, A. Ploeg, A.T. van der |
2010-04-01
|
|
Reply to the letter to the editor by Papadimas et al.: "Bone mineral density in adult patients with Pompe disease"
(Article)
Berg, L.E.M. van den Zandbergen, A.A.M. Capelle, C.I. van Vries, J.M. de Hop, W.C.J. Hout, J.M.P. van den Reuser, A.J.J. Zillikens, M.C. Ploeg, A.T. van der |
2010-01-01
|
|
Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13T>G genotype rarely reveals abnormalities
(Article)
Beek, N.A.M.E. van der Soliman, O.I.I. Capelle, C.I. van Geleijnse, M.L. Vletter, W.B. Kroos, M.A. Reuser, A.J.J. Frohn-Mulder, I.M.E. Doorn, P.A. van Ploeg, A.T. van der |
2008-12-15
|